Vision Loss From Giant Cell Arteritis in Patients With Other Ocular Diagnoses

被引:1
|
作者
Nichani, Prem [1 ]
Biousse, Valerie [2 ,3 ]
Newman, Nancy J. [2 ,3 ]
Micieli, Jonathan A. [4 ,5 ]
机构
[1] Univ Toronto, Fac Med, Toronto, ON, Canada
[2] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA
[4] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
ANTERIOR SEGMENT ISCHEMIA; ANGLE-CLOSURE GLAUCOMA;
D O I
10.1097/WNO.0000000000001064
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Vision problems from giant cell arteritis (GCA) can be difficult to diagnose as patients may present with vision loss in the absence of systemic symptoms, have other comorbidities that affect inflammatory blood markers, or have other ocular diagnoses. We present 3 cases illustrating this point including a patient with advanced glaucoma with worsening vision from posterior ischemic optic neuropathy from GCA, a patient with arteritic anterior ischemic optic neuropathy (AAION) erroneously diagnosed as optic neuritis without elevated inflammatory blood markers due to corticosteroid use, and a patient with AAION and a history of nonarteritic anterior ischemic optic neuropathy in her fellow eye and untreated obstructive sleep apnea. GCA should be kept in the differential diagnosis for patients over 50 years of age even if they carry other ocular diagnoses. Temporal artery biopsy remains the gold standard for GCA diagnosis and is often required in equivocal cases. (C) 2020 by North American Neuro-Ophthalmology Society
引用
收藏
页码:E254 / E258
页数:5
相关论文
共 50 条
  • [1] Vision loss in giant cell arteritis
    Donaldson, Laura
    Margolin, Edward
    PRACTICAL NEUROLOGY, 2022, 22 (02) : 138 - +
  • [2] Risk for Vision Loss and Relapse in Patients with Giant Cell Arteritis
    Haaversen, Anne Bull
    Diamantopoulos, Andreas
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Amsler, Jennifer
    Kysela, Iveta
    Tappeiner, Christoph
    Seitz, Luca
    Christ, Lisa
    Scholz, Godehard
    Stalder, Odile
    Kollert, Florian
    Reichenbach, Stephan
    Villiger, Peter M.
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [4] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Jennifer Amsler
    Iveta Kysela
    Christoph Tappeiner
    Luca Seitz
    Lisa Christ
    Godehard Scholz
    Odile Stalder
    Florian Kollert
    Stephan Reichenbach
    Peter M. Villiger
    Arthritis Research & Therapy, 23
  • [5] Postural vision loss in giant cell arteritis
    Diego, M
    Margo, CE
    JOURNAL OF NEURO-OPHTHALMOLOGY, 1998, 18 (02) : 124 - 126
  • [6] Treatment of Vision Loss in Giant Cell Arteritis
    Ryan A. Scheurer
    Andrew R. Harrison
    Michael S. Lee
    Current Treatment Options in Neurology, 2012, 14 : 84 - 92
  • [7] Treatment of Vision Loss in Giant Cell Arteritis
    Scheurer, Ryan A.
    Harrison, Andrew R.
    Lee, Michael S.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (01) : 84 - 92
  • [8] Ocular findings and differential diagnoses in giant cell arteritis (Arteriitis cranialis)
    Schmidt, D.
    Ness, T.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (02): : 117 - +
  • [9] Slowly progressive vision loss in giant cell arteritis
    Galor, A
    Lee, MS
    ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (03) : 416 - 418
  • [10] Predictors of Permanent Vision Loss in Giant Cell Arteritis
    Tucker, Susan M.
    Haas, Sara J.
    Rizvi, Tasneem Zaihra
    NEURO-OPHTHALMOLOGY, 2025, 49 (01) : 60 - 68